Publications by authors named "Edson V da Cunha Filho"
Article Synopsis
- The study aimed to understand stillbirth ratios and investigate the causes of fetal mortality by analyzing medical records from multiple obstetric care centers over a nine-year period.
- A total of 3,390 stillbirth cases were reviewed, showing a decrease in the stillbirth ratio from 10.74 to 9.31 per 1,000 live births, with common causes being intrauterine hypoxia and unspecified reasons.
- The study highlights a need for standardized investigation practices for stillbirths since many cases lacked comprehensive testing, especially for unspecified causes of death.
Background: Considering the worldwide importance of preeclampsia, especially in Brazil, the screening of pregnant women at greater risk of developing the disease and the application of preventive measures are essential. This study aimed to assess the medical performance in this context in Brazil.
Methods: A survey was developed to quantify the number of physicians who prescribe acetylsalicylic acid (ASA) and/or calcium for preeclampsia prevention.
Risk stratification for small for gestational age for the Brazilian population: a secondary analysis of the Birth in Brazil study.
Sci Rep
September 2020
Risk-stratification screening for SGA has been proposed in high-income countries to prevent perinatal morbidity and mortality. There is paucity of data from middle-income settings. The aim of this study is to explore risk factors for SGA in Brazil and assess potential for risk stratification.
View Article and Find Full Text PDFObjectives: Eclampsia results in high morbidity and mortality, so it is important to identify clinical and laboratorial aspects that may be useful as potential markers to differentiate women at higher risk. Thus, we aim to identify, among women with preeclampsia, aspects that may increase the risk to develop eclampsia.
Study Design: Retrospective cohort study.
Objective: To analyze endocan-1, a biomarker of vascular endothelial related pathologies, and the placental growth factor (PlGF), an angiogenic factor and a placental dysfunction marker in patients with preeclampsia (PE).
Methods: Case-control study conducted at Hospital São Lucas, in the city of Porto Alegre, Brazil. Endocan-1 and PlGF levels were quantified in the maternal plasma using the MagPlexTH-C microsphere system (MAGPIX System, Luminex, Austin, Texas, US) and evaluated through analysis of covariance (ANCOVA) and adjusted by body mass index (BMI), gestational age and maternal age.